1. What is the Chemxpert database?

Chemxpert database is a techno-commercial information platform developed and operated by Lifescience Intellipedia Pvt. Ltd. Our data provides valuable insights regarding sourcing, marketing, development, and regulatory functions for the entire Lifescience industry. The different industries covered by our data encompass APIs, FDFs, pharma intermediates, paints, dyes, polymers, biotechnology, biochemical, food additives, nutraceuticals, etc.

2. How can I subscribe to the Chemxpert database?

You can gain access to the Chemxpert database after subscribing to it by visiting this link: - https://chemxpert.com/pricing

3. How many countries' data is available on your portal?

The Chemxpert database covers more than 200 countries. We are working in the direction of expanding our data coverage in more countries.

4. What are the different sources you use for obtaining information?

The different sources we use for data collection are as follows: - • Primary researc • DMF, ANDA, & CEP list • Conferences, Exhibitions, & Tradeshow • Company annual reports • DMF, ANDA, & CEP list • Subject matter experts & KOL survey. Apart from these, our other valuable sources include application-wise manufacturers list, subscribed and non-subscribed databases, corporate partners, US FDA Orange book, publicly available sources, industry associates, national statistics, regulatory websites, etc. You can gain access to the Chemxpert database after subscribing to it by visiting this link: -https://chemxpert.com/sources

5. What is the expected time for account activation?

Your Chemxpert account will be activated instantly if the payment is made through our website. If you choose to use RTGS, NEFT, or IMPS systems for payment, your account will be activated within 24 hours.

06 Mar 2024
Admin
News Article

C4 Therapeutics and Merck KGaA Partners for Oncogenic Proteins

C4 Therapeutics and Merck KGaA, Darmstadt, Germany, Team Up in Strategic Discovery Collaboration Against Critical Oncogenic Proteins

C4 Therapeutics, Inc. (C4T) (Nasdaq: CCCC) has announced a collaboration with Merck KGaA, Darmstadt, Germany, operating as EMD Serono in the U.S. and Canada, to develop two targeted protein degraders against oncogenic proteins within C4T's internal discovery pipeline.

Statement from CEO: C4 Therapeutics

Andrew Hirsch, President and CEO of C4 Therapeutics, expressed enthusiasm for the partnership, emphasizing its potential to transform cancer treatment. He highlighted the complementary strengths of both organizations and C4T's track record in developing innovative targeted protein degrader medicines.

Merck KGaA Leader on Collab

Paul Lyne, Head of Research Unit Oncology at Merck KGaA, Darmstadt, Germany, also emphasized the collaboration's importance in expanding Merck's portfolio in targeted protein degradation projects. Lyne mentioned the utilization of C4 Therapeutics' expertise to advance degrader candidates and improve patient outcomes.

Funding Post Collaboration

According to the agreement, C4T will receive an upfront payment of $16 million and ongoing funding for research efforts.
The collaboration offers the potential for C4T to earn up to approximately $740 million in various milestone payments, along with royalties on future sales for each program.

Responsibilities Post Collab

C4T will utilize its TORPEDO® platform to discover degraders targeting oncogenic proteins, while Merck KGaA, Darmstadt, Germany, will handle clinical development and commercialization.

Futuristic Step

This collaboration marks a significant step in cancer therapy research, bringing together the strengths of C4 Therapeutics and Merck KGaA, Darmstadt, Germany, to address critical medical needs in oncology.

Let’s apply Data-Driven Pricing to Your APIs

Sick and tired of always wondering if you are being asked to pay the right price for your APIs? This empowers you with the answers you need to make the right decisions in the Global API market.

Chemxpert Database is one of the biggest and most comprehensive directories of pharma and chemicals, manufacturers, suppliers and information. Provided with current information on prices, demand and transactions, it gives you instant feedback on whether you are buying what is right and at the right time.

Start using market intelligence today and allow yourself to be in control in the API market.

Check it out today and make more informed sourcing decisions! Learn More!